The Combination Therapy With Ra-223 and Enzalutamide
Clinical trial NCT03305224 · UNKNOWN
Trial details
- NCT number
- NCT03305224
- Sponsor
- Taro Iguchi, MD, PHD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-27
- Primary completion
- 2021-10-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.